| Dr Jason Reid, MD | |
|
98 Poplar St, Blackfoot, ID 83221-1799 | |
| (208) 785-4100 | |
| Not Available |
| Full Name | Dr Jason Reid |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 98 Poplar St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962727834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | M-11929 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bingham Memorial Hospital | Blackfoot, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bmh Inc | 8426149758 | 124 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch eTNS system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.
Intertek (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing services to meet the additional requirement to disclose the presence of 15 new REACH Substances of Very High Concern (SVHC).
Researchers from Brigham and Women's Hospital and the University of Murcia, Spain, have shed new light on why people who carry a common genetic mutation may be more at risk for developing type 2 diabetes. By carefully studying healthy subjects, researchers were able to chart the effect of melatonin supplements on blood sugar control.
CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.
On International Human Rights Day, as the European Commission (EC) and the Government of India meet in Brussels to finalise a European Union (EU)-India free trade agreement, the International Treatment Preparedness Coalition (ITPC) calls on Indian negotiators to put the right to health of its citizens and of the fifteen million HIV-positive people worldwide needing treatment above the pharmaceutical companies' interests and profits.
› Verified 2 days ago
| Entity Name | Bmh Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255539193 PECOS PAC ID: 8426149758 Enrollment ID: O20071018000897 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch eTNS system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.
Intertek (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing services to meet the additional requirement to disclose the presence of 15 new REACH Substances of Very High Concern (SVHC).
Researchers from Brigham and Women's Hospital and the University of Murcia, Spain, have shed new light on why people who carry a common genetic mutation may be more at risk for developing type 2 diabetes. By carefully studying healthy subjects, researchers were able to chart the effect of melatonin supplements on blood sugar control.
CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.
On International Human Rights Day, as the European Commission (EC) and the Government of India meet in Brussels to finalise a European Union (EU)-India free trade agreement, the International Treatment Preparedness Coalition (ITPC) calls on Indian negotiators to put the right to health of its citizens and of the fifteen million HIV-positive people worldwide needing treatment above the pharmaceutical companies' interests and profits.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Reid, MD 30 N 1900 E Rm 4c104, U Of U School Of Medicine, Internal Medicine Residency, Salt Lake City, UT 84132-0002 Ph: (801) 581-7899 | Dr Jason Reid, MD 98 Poplar St, Blackfoot, ID 83221-1799 Ph: (208) 785-4100 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch eTNS system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.
Intertek (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing services to meet the additional requirement to disclose the presence of 15 new REACH Substances of Very High Concern (SVHC).
Researchers from Brigham and Women's Hospital and the University of Murcia, Spain, have shed new light on why people who carry a common genetic mutation may be more at risk for developing type 2 diabetes. By carefully studying healthy subjects, researchers were able to chart the effect of melatonin supplements on blood sugar control.
CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.
On International Human Rights Day, as the European Commission (EC) and the Government of India meet in Brussels to finalise a European Union (EU)-India free trade agreement, the International Treatment Preparedness Coalition (ITPC) calls on Indian negotiators to put the right to health of its citizens and of the fifteen million HIV-positive people worldwide needing treatment above the pharmaceutical companies' interests and profits.
› Verified 2 days ago